Drug · DIN 02489449
ZIRABEV
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 25, 2019; first marketed September 25, 2019.
- Drug Identification Number (DIN)
- 02489449
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Bevacizumab L01FG01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BEVACIZUMAB | 400 MG | 16 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 14, 2019: NOC 22292New Drug Submission (NDS)
Other DINs named ZIRABEV
- DIN 02489430 · Marketed